Eighteen months might sound like a long time , but in vaccine years , it 's a blink . 
That 's the long end of the Trump administration 's time window for developing a coronavirus vaccine , and some leaders in the field say this is too fast -- and could come at the expense of safety . 
Vaccine trials typically start with testing in animals before launching into a three phase process . 
Mark Feinberg , president and CEO of the International AIDS Vaccine Initiative , told Stat that while he recognizes the importance of animal trials , the urgency of the current public emergency makes it worth the trade off . 
For more on the vaccine trials and vaccine development , read the full story here : 
